article thumbnail

In an increasingly hot biotech market, protecting IP is key

TechCrunch

John Flavin is founder and CEO of Portal Innovations, LLC. 2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 billion invested across 1,073 deals — the market for new innovations remains strong.

Biotech 240
article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 175
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

This VC built a lab to make building biotech startups easier

TechCrunch

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. where do you travel to in your mind? The Bay Area?

Biotech 203
article thumbnail

Life Sciences Executive Search Firms: Bridging Biotech and Leadership

N2Growth Blog

The life sciences industry is characterized by unique challenges and complexities, requiring leaders who deeply understand scientific advancements, regulatory frameworks, and highly dynamic market conditions. The rapid pace of innovation and advancement in the sector further compounds the challenges of leadership recruitment.

Biotech 94
article thumbnail

Will enterprises soon keep their best gen AI use cases under wraps?

CIO

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations. It takes several iterations over weeks to get the drawings right.

article thumbnail

TechCrunch+ roundup: Using predictive LTV, Boston VC survey, active learning for ML teams

TechCrunch

Thanks very much for reading, Walter Thompson Editorial Manager, TechCrunch+ @yourprotagonist Using predictive LTV to juice up marketing campaigns Going private: A guide to PE tech acquisitions Image Credits: PM Images (opens in a new window) / Getty Images For private equity firms in search of bargains, now is a great time to be alive. .”

Biotech 212